about
High rates of virological suppression in a cohort of human immunodeficiency virus-positive adults receiving antiretroviral therapy in ethiopian health centers irrespective of concomitant tuberculosisA Clinical Scoring Algorithm for Determination of the Risk of Tuberculosis in HIV-Infected Adults: A Cohort Study Performed at Ethiopian Health Centers.Screening for cryptococcal antigenemia using the lateral flow assay in antiretroviral therapy-naïve HIV-positive adults at an Ethiopian hospital clinic.Factors Associated with Early Mortality in HIV-Positive Men and Women Investigated for Tuberculosis at Ethiopian Health Centers.Retention in care among HIV-positive patients initiating second-line antiretroviral therapy: a retrospective study from an Ethiopian public hospital clinicIntensified tuberculosis case-finding in HIV-positive adults managed at Ethiopian health centers: diagnostic yield of Xpert MTB/RIF compared with smear microscopy and liquid culture.Development of an algorithm for determination of the likelihood of virological failure in HIV-positive adults receiving antiretroviral therapy in decentralized care.High rates of viral suppression in a cohort of HIV-positive adults receiving ART in Ethiopian health centers irrespective of concomitant tuberculosisDetection of lipoarabinomannan in urine for identification of active tuberculosis among HIV-positive adults in Ethiopian health centres.Long-term Outcome of Antiretroviral Treatment in Patients With and Without Concomitant Tuberculosis Receiving Health Center-Based Care-Results From a Prospective Cohort Study.Validation of the Viral Load Testing Criteria - an algorithm for targeted viral load testing in HIV-positive adults receiving antiretroviral therapyAge and sex differences in soluble ACE2 may give insights for COVID-19
P50
Q35071944-919ABA06-890E-4D0D-8CE9-7332404ED15DQ35072083-D0749278-4C71-4E40-967D-87D82E1E9D84Q35849300-DA76AF54-BAA3-4294-BC12-EB3DED9CD3DBQ36043944-FF94261D-4FCD-4073-BE75-C8CEB6E160E3Q36460759-18BD754C-5EA0-4E40-AAC1-ABE5D4A59C40Q37505042-F1B236C9-EF60-46CE-990F-D3D207472D29Q40039231-6EA3AAB8-09F8-4EDC-8746-9F5E37816631Q41663547-46418BD1-7ECD-4E95-915F-75376C7A17F4Q42221349-56383672-4DAC-4225-B8FA-CA22D91F3373Q46634665-E2A8A3BE-BB8F-4FF6-B2C2-6F97D6095F95Q90961514-5BCEBF39-2EDB-49EB-AE32-71FE12263972Q94918222-0EE569D1-614C-4B90-B5F6-CFB8636128B0
P50
description
forskare
@sv
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
A Reepalu
@ast
A Reepalu
@es
A Reepalu
@nl
Anton Reepalu
@en
Anton Reepalu
@sv
type
label
A Reepalu
@ast
A Reepalu
@es
A Reepalu
@nl
Anton Reepalu
@en
Anton Reepalu
@sv
prefLabel
A Reepalu
@ast
A Reepalu
@es
A Reepalu
@nl
Anton Reepalu
@en
Anton Reepalu
@sv
P106
P108
P1153
54684746300
P21
P31
P496
0000-0003-1690-8921